Angiotensin-converting Enzyme-related Cough among Chinese-Americans

American Journal of Medicine

Volumn 123, Issue 2, 2010, Pages

  Tseng, Daniel S ^a   Kwong, Jan ^a   Rezvani, Firozeh ^a   Coates, Ashley O ^b  

^a Kaiser Permanente of Northern California ^*  (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Antihypertensive agents; Cough; Lisinopril; Race

Indexed keywords

LISINOPRIL;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; ASIAN AMERICAN; CHINESE; CHRONIC DISEASE; COUGHING; DATA BASE; DRUG WITHDRAWAL; ETHNICITY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; TREATMENT REFUSAL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASIAN AMERICANS; CALIFORNIA; COHORT STUDIES; COUGH; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; LISINOPRIL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 74549198796     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.06.032     Document Type: Article

References (25)

1. Minor D.S., Wofford M.R., and Jones D.W. Racial and ethnic differences in hypertension. Curr Atheroscler Rep. 10 (2008) 121-127
2. Kramer H., Han C., Wendy P., et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 14 (2004) 963-970
3. Jones D.W. Hypertension in East Asia. Am J Hypertens. 8 (1995) 111S-114S
4. Gu D., Reynolds K., Wu X., et al. Prevalence, awareness, treatment and control of hypertension in China. Hypertension 40 (2002) 920-927
5. Ogihara T., and Rakugi H. Hypertension in the elderly. A Japanese perspective. Drugs Aging 22 (2005) 297-314
6. Zhou H., Koshakji R.P., Silberstein D.J., et al. Racial differences in drug response. N Engl J Med. 320 (1989) 565-570
7. Israili Z.H., and Hall D.W. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med. 117 (1992) 234-242
8. Woo K.S., Norris R.M., and Nicholls G. Racial differences in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol. 75 (1995) 967-968
9. Nishizawa A. Angiotensin-converting enzyme inhibitor induced cough among Asians. Proc UCLA Health 4 (2000) 35-38
10. United States Department of Commerce. United States Census 2000 (July 2002). http://www.census.gov/main/www/cen2000.html
11. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82 (1992) 703-710
12. Quan H., Wang F., Schopflocher D., et al. Development and validation of a surname list to define Chinese ethnicity. Med Care 44 (2006) 328-333
13. Lauderdale D.S., and Kestenbaum B. Asian American identification by surname. Popul Res Policy Rev. 19 (2000) 283-300
14. CIA World Factbook. https://www.cia.gov/library/publications/the-world-factbook/geos/ch.html
15. Brownstone D.M. The Chinese-American Heritage (1988), Facts on File, New York; Oxford, UK
16. Bo W., Hui L., Daru L., et al. Genetic evidence supports demic diffusion of Han culture. Nature 431 (2004) 302-304
17. Gibson G.R. Enalapril-induced cough. Arch Intern Med. 149 (1989) 2701-2703
18. Strocchi E., Valtancoli G., and Ambrosioni E. The incidence of cough during treatment with angiotensin converting enzyme inhibitors. J Hypertens. 7 suppl 6 (1989) S308-S309
19. Tugwell S., and Stokes G.S. Angiotensin-converting enzyme inhibitor agents and respiratory symptoms. [Letter]. Med J Aust. 147 (1987) 263-264
20. Perkins R.C. Evaluating the Passel-Word Spanish Surname List: 1990 Decennial Census Post Enumeration Survey Results. (Population Division Working Paper No 4) (1993), Population Division, U.S. Bureau of the Census, Washington, DC
21. Fiscella K., and Fremont A. Use of geocoding and surname analysis to estimate race and ethnicity. Health Serv Res. 41 (2006) 1482-1500
22. The hundred families surnames. http://en.wikipedia.org/wiki/Hundred_Family_Surnames
23. Pfeffer M.A., McMurray J.J., Velazquez E.J., et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 349 (2003) 1893-1906
24. Strippoli G.F., Craig M., Deeks J.J., et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 329 (2004) 828
25. Barnett A.H., Bain S.C., Bouter P., et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 351 (2004) 1952-1961